Evidence map›Paper›PMID 35789457›Full record

ArticleMedical & biological engineering & computing2022

Sparse principal component analysis based on genome network for correcting cell type heterogeneity in epigenome-wide association studies.

Rui Miao, Qi Dang, Jie Cai, Hai-Hui Huang, Sheng-Li Xie, Yong Liang

Abstract read
PubMed Publisher
In one paragraph

Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Rui MiaoBasic Teaching Department, ZhuHai Campus of ZunYi Medical University, Zhu Hai, China.
Qi DangInstitute of Systems Engineering, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
Jie CaiInstitute of Systems Engineering, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
Hai-Hui HuangInstitute of Systems Engineering, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China.
Sheng-Li XieGuangdong-HongKong-Macao Joint Laboratory for Smart Discrete Manufacturing, Guangzhou, 510006, China.
Yong LiangState Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China. yliang@must.edu.mo.
Macau University of Science and Technology · MOGuangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality · CNZunyi Medical University · CN

Funding

Macau Science and Technology Development Funds Grands e Tecnologia do Estado de Mato Grosso do Sul No.0158/2019/A3
6 · The paper itself

Abstract

In epigenome-wide association studies (EWAS), the mixed methylation expression caused by the combination of different cell types may lead the researchers to find the false methylation site related to the phenotype of interest. To correct the EWAS false discovery, some non-reference models based on sparse principal component analysis (sparse PCA) have been proposed. These models assume that all methylation sites have the same priori probability in each PC load. However, it is known that there already has gene network structure corresponding to the methylation site. How to integrate this genome network knowledge into the sparse PCA models to enhance the performance of existing models is an open research problem. We introduce GN-ReFAEWAS, a non-reference analysis model which integrates the prior gene network structure into the PCA framework to control the false discovery in EWAS. We used one simulated data set, three real data sets, and three additional tests for experiments and compared with four existing models. Experimental results show that the GN-ReFAEWAS model is better than the existing model by 2-90% in the indicators of sensitivity, specificity, genomic control factor λ, and correlation coefficient factor cov with known cell phenotype ratio.

Indexed as

Epigenesis, GeneticEpigenomeDNA MethylationGenome-Wide Association StudyPrincipal Component AnalysisEWASGene networkGN-ReFAEWASSparse PCA

Identifiers

PMID35789457
OpenAlexW4283793157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.